Dr. Adrian Jinich, a postdoctoral associate in medicine in the Division of Infectious Diseases at Weill Cornell Medicine, has been selected as a 2019 Hanna H. Gray Fellow by the Howard Hughes Medical Institute (HHMI).
Cornell Tech and Weill Cornell Medicine have been awarded a Robert Wood Johnson Foundation (RWJF) grant that will fund interdisciplinary research on the role of technology among home health aides caring for adults with heart failure.
Dr. Laura Alonso has been named chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Sept. 1. Dr. Alonso will also lead the Joan and Sanford I. Weill Center for Metabolic Health at Weill Cornell Medicine.
The most common type of non-Hodgkin lymphoma depends for its aggressive growth and survival on an enzyme that can be therapeutically targeted with a novel compound developed at Cornell University, scientists at Weill Cornell Medicine and Cornell’s Ithaca campus have discovered.
States that require prescribers to register with and use prescription drug monitoring programs in most clinical circumstances saw notably fewer opioid prescriptions and reduced opioid-related hospital use by Medicaid patients compared to states with weak or no drug monitoring program mandates.
A new study presents a technique to identify viruses and bacteria in the human body and quantify injuries to organs by using dead fragments of DNA, called cell-free DNA, that roam throughout the bloodstream and urine.
Medical conditions and health habits that affect blood flow in the brain—or cerebrovascular risk factors—are associated with a subsequent diagnosis of Parkinson’s disease, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian investigators.
Scientists at Weill Cornell Medicine have developed a system that uses cancer patients’ own cells to evaluate the efficacy of treatments. The scientists used their new testbed to show that a two-drug combination potentially would benefit many patients with acute myeloid leukemia (AML).
Memorial Sloan Kettering nanotechnology researcher Dr. Daniel Heller recently worked with an artist to create nanotube-based paints that can be used to test for cancer and diabetes — and to make a new form of visual art.
The Class of 2023 adds to Weill Cornell Medicine’s diverse community. Its students, nearly two-thirds of whom are bilingual, hail from 16 countries. Women comprise more than half the class, and 23 percent are from groups that are underrepresented in medicine.
A team of scientists from Weill Cornell Medicine and The Rockefeller University has illuminated the basic mechanism of Piezo proteins, which function as sensors in the body for mechanical stimuli such as touch, bladder fullness and blood pressure.
Dr. Rahul Sharma, emergency physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and chairman of the Department of Emergency Medicine at Weill Cornell Medicine, has been named a top 25 innovator in the healthcare industry by Modern Healthcare. The inaugural list recognizes executives who are initiating and leading transformation across the healthcare industry.
Dr. Nir Uriel, a renowned leader in the field of heart failure, mechanical circulatory support and heart transplantation, has been appointed director of advanced heart failure and cardiac transplantation at NewYork-Presbyterian, effective August 16.
Dr. Kyu Rhee, an associate professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine, has been awarded a Physician-Scientist Institutional Award by the Burroughs Wellcome Fund.
Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to launch a program designed to increase the number of underrepresented minority medical and graduate students, residents and postdoctoral fellows committed to careers in health equity and global health research.